Fertility centre directed to refund Rs 15L to AP couple

VISAKHAPATNAM: The district consumer disputes redressal commission-I, in a recent order, directed two doctors and coordinator of a Vizag-based fertility centre to refund 15 lakh to a couple for failing to provide a child through surrogacy despite taking the huge amount from them. The centre was also asked to pay a compensation of 1 lakh to the couple besides 10,000 towards legal expenses.

Slamming Universal Srushti Fertility and Research Centre, Rahimunnisa Begum, woman member of the consumer body, said it resorted to unfair trade practices. The couple from Vizag city – Illibilli Ugandhar and Illibilli Ekta – were married for 12 years but had no kids. After coming across an advertisement put up by USFRC, the childless couple approached the fertility centre where doctors suggested to have a child through surrogacy. The couple agreed to pay 15 lakh to the fertility centre as service charges to doctors in the fifth month of surrogate mother’s pregnancy.

They paid 2 lakh in September 2019 and made the final payment in May 2020. But the surrogate mother was not shown to the couple as promised. The fertility centre told the couple that the surrogate mother will give birth to a baby in August 2020. However, in July 2020, the two doctors who they were dealing with – Dr Patchipala Namrata and Dr Tirumala – were arrested by Vizag city police along with six others on child trafficking charges. When the doctors were released on bail, the couple asked them to return their money but they kept giving all kinds of excuses. Ugandhar and Ekta then filed a petition in the consumer forum.

A senior police officer told STOI that the fertility centre was sealed after the child trafficking incident came to light. However, the hospital later reopened and has been functioning as usual.

Related Posts

Indian Pharma Majors Plan to Invest in US

National Harbor (US): Top Indian pharmaceutical companies, including at least three from Hyderabad, are all set to announce major investments to set up new facilities in the United States during…

Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

Emcure Pharmaceuticals Ltd on Tuesday reported a 24 per cent increase in consolidated net profit at ₹243.74 crore in the fourth quarter ended March 2026 on the back of robust…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Indian Pharma Majors Plan to Invest in US

Indian Pharma Majors Plan to Invest in US

Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification